Loading...
Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer
LESSONS LEARNED. The androgen receptor (AR) is present in most breast cancers (BC), but its exploitation as a therapeutic target has been limited. This study explored the activity of dehydroepiandrosterone (DHEA), a precursor being transformed into androgens within BC cells, in combination with an a...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656524/ https://ncbi.nlm.nih.gov/pubmed/30591548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0243 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|